S, L., M, P., E, C., R, A., M, M., S, S., . . . D, M. (2025). Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies. The oncologist, 30(4), . https://doi.org/10.1093/oncolo/oyaf040
Chicago Style (17th ed.) CitationS, Lopez-Tarruella, et al. "Retrospective Analysis to Validate the CTS5 in Patients from El Álamo IV Registry and GEICAM Adjuvant Studies." The Oncologist 30, no. 4 (2025). https://doi.org/10.1093/oncolo/oyaf040.
MLA (9th ed.) CitationS, Lopez-Tarruella, et al. "Retrospective Analysis to Validate the CTS5 in Patients from El Álamo IV Registry and GEICAM Adjuvant Studies." The Oncologist, vol. 30, no. 4, 2025, https://doi.org/10.1093/oncolo/oyaf040.
Warning: These citations may not always be 100% accurate.